REPCO

{
    key:"uid": string:"eayrf7c7zcoxaro2tisteiwv24i",
    key:"title": {
        key:"en": {
            key:"value": string:"What's right: Pharma companies making progress in cancer treatment"
        }
    },
    key:"subtitle": {},
    key:"summary": {
        key:"en": {
            key:"value": string:"Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer."
        }
    },
    key:"content": {
        key:"en": {
            key:"value": string:"Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer."
        }
    },
    key:"titleTranslations": {
        key:"bg": {
            key:"value": string:"Правилно е: Фармацевтични компании напредват в лечението на рак",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"Co je správné: Farmaceutické společnosti dosahují pokroku v léčbě rakoviny",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"Was richtig ist: Pharmaunternehmen machen Fortschritte bei der Krebsbehandlung",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"Τι είναι σωστό: Οι φαρμακευτικές εταιρείες κάνουν πρόοδο στη θεραπεία του καρκίνου",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"What's right: Pharma companies making progress in cancer treatment",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"Lo que es correcto: Las empresas farmacéuticas están avanzando en el tratamiento del cáncer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"Mikä on oikein: Lääketeollisuus tekee edistystä syövän hoidossa",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"Qu'est-ce qui est juste : Les entreprises pharmaceutiques progressent dans le traitement du cancer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"Što je ispravno: Farmaceutske tvrtke napreduju u liječenju raka",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"Mi a helyes: A gyógyszeripari cégek előrelépéseket tesznek a rákkezelésben",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"Cosa c'è di giusto: le aziende farmaceutiche stanno facendo progressi nel trattamento del cancro",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"Wat is juist: Farmaceutische bedrijven maken vooruitgang in de behandeling van kanker",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"Co jest właściwe: Firmy farmaceutyczne robią postępy w leczeniu raka",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"O que está certo: Empresas farmacêuticas fazendo progressos no tratamento do câncer",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"Ce este corect: Companiile farmaceutice fac progrese în tratamentul cancerului",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": string:"Фармацевтические компании добиваются успехов в лечении рака",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sk": {
            key:"value": string:"Čo je správne: Farmaceutické spoločnosti dosahujú pokrok v liečbe rakoviny",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": string:"Vad är rätt: Läkemedelsföretag gör framsteg inom cancerbehandling",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"tr": {
            key:"value": string:"İlaç şirketleri kanser tedavisinde ilerleme kaydediyor",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": string:"Що правильно: Фармацевтичні компанії досягають успіхів у лікуванні раку",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        }
    },
    key:"subtitleTranslations": {
        key:"bg": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"cs": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"de": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"el": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"en": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"es": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"fi": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"fr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"hr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"hu": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"it": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"nl": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"pl": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"pt": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"ro": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"summaryTranslations": {
        key:"bg": {
            key:"value": string:"<p>Фармацевтичните компании AstraZeneca и MSD правят значителен напредък в лечението на ракови заболявания, които са известни с трудността си на лечение, като тумори на пикочния мехур, белодробни ракове и определени форми на рак на гърдата.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"<p>Farmaceutické společnosti AstraZeneca a MSD dosahují značného pokroku v léčbě rakovin, které jsou známé svou obtížností na léčbu, jako jsou nádory močového měchýře, rakoviny plic a určité formy rakoviny prsu.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"<p>Die Pharmaunternehmen AstraZeneca und MSD machen erhebliche Fortschritte bei der Behandlung von Krebsarten, die als schwer behandelbar bekannt sind, wie z. B. Blasentumoren, Lungenkrebs und bestimmte Formen von Brustkrebs.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"<p>Οι φαρμακευτικές εταιρείες AstraZeneca και MSD κάνουν σημαντική πρόοδο στη θεραπεία καρκίνων που είναι γνωστοί για την δυσκολία τους στη θεραπεία, όπως οι όγκοι της ουροδόχου κύστης, οι καρκίνοι του πνεύμονα και ορισμένες μορφές καρκίνου του μαστού.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"<p>Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"<p>Las compañías farmacéuticas AstraZeneca y MSD están logrando un progreso considerable en el tratamiento de cánceres que son conocidos por ser difíciles de tratar, como los tumores de vejiga, los cánceres de pulmón y ciertas formas de cáncer de mama.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"<p>Lääkeyhtiöt AstraZeneca ja MSD tekevät merkittävää edistystä syöpien hoidossa, jotka tunnetaan vaikeasti hoidettavina, kuten rakko- ja keuhkosyövät sekä tietyt rintasyövän muodot.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"<p>Les entreprises pharmaceutiques AstraZeneca et MSD réalisent des progrès considérables dans le traitement des cancers qui sont connus pour être difficiles à traiter, tels que les tumeurs de la vessie, les cancers du poumon et certaines formes de cancer du sein.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"<p>Farmaceutske tvrtke AstraZeneca i MSD postižu značajan napredak u liječenju raka koji su poznati po tome što su teški za liječenje, poput tumora mjehura, raka pluća i određenih oblika raka dojke.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"<p>AstraZeneca és az MSD gyógyszergyárak jelentős előrelépéseket tesznek a nehezen kezelhető rákos megbetegedések, például a hólyagdaganatok, tüdőrákok és bizonyos formájú emlőrákok kezelésében.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"<p>Le aziende farmaceutiche AstraZeneca e MSD stanno facendo notevoli progressi nel trattamento dei tumori che sono noti per essere difficili da trattare, come i tumori della vescica, i tumori polmonari e alcune forme di cancro al seno.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"<p>De farmaceutische bedrijven AstraZeneca en MSD boeken aanzienlijke vooruitgang in de behandeling van kankers die bekend staan om moeilijk te behandelen te zijn, zoals blaastumoren, longkankers en bepaalde vormen van borstkanker.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"<p>Firmy farmaceutyczne AstraZeneca i MSD poczyniły znaczne postępy w leczeniu nowotworów, które są znane z trudności w leczeniu, takich jak guzy pęcherza, nowotwory płuc i niektóre formy raka piersi.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"<p>As empresas farmacêuticas AstraZeneca e MSD estão fazendo progressos consideráveis no tratamento de cânceres que são conhecidos por serem difíceis de tratar, como tumores na bexiga, cânceres de pulmão e certas formas de câncer de mama.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"<p>Companiile farmaceutice AstraZeneca și MSD fac progrese considerabile în tratamentul cancerelor care sunt cunoscute pentru dificultatea lor de tratament, cum ar fi tumorile vezicii urinare, cancerele pulmonare și anumite forme de cancer mamar.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": string:"<p>Farmaceutické spoločnosti AstraZeneca a MSD dosahujú značný pokrok v liečbe rakovín, ktoré sú známe svojou ťažkou liečbou, ako sú nádory močového mechúra, rakoviny pľúc a určité formy rakoviny prsníka.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": string:"<p>İlaç şirketleri AstraZeneca ve MSD, mesane tümörleri, akciğer kanserleri ve belirli meme kanseri türleri gibi tedavi edilmesi zor olarak bilinen kanserlerin tedavisinde önemli ilerlemeler kaydediyor.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"contentTranslations": {
        key:"bg": {
            key:"value": string:"<p>Фармацевтичните компании AstraZeneca и MSD правят значителен напредък в лечението на ракови заболявания, които са известни с трудността си на лечение, като тумори на пикочния мехур, рак на белия дроб и определени форми на рак на гърдата.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"cs": {
            key:"value": string:"<p>Farmaceutické společnosti AstraZeneca a MSD dosahují značného pokroku v léčbě rakovin, které jsou známé tím, že se obtížně léčí, jako jsou nádory močového měchýře, rakoviny plic a některé formy rakoviny prsu.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"de": {
            key:"value": string:"<p>Die Pharmaunternehmen AstraZeneca und MSD machen erhebliche Fortschritte bei der Behandlung von Krebsarten, die als schwer behandelbar bekannt sind, wie Blasentumoren, Lungenkrebs und bestimmte Formen von Brustkrebs.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"el": {
            key:"value": string:"<p>Οι φαρμακευτικές εταιρείες AstraZeneca και MSD κάνουν σημαντική πρόοδο στη θεραπεία καρκίνων που είναι γνωστοί για την δυσκολία τους στη θεραπεία, όπως οι όγκοι της ουροδόχου κύστης, οι καρκίνοι του πνεύμονα και ορισμένες μορφές καρκίνου του μαστού.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"en": {
            key:"value": string:"<p>Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"es": {
            key:"value": string:"<p>Las compañías farmacéuticas AstraZeneca y MSD están logrando un progreso considerable en el tratamiento de cánceres que son conocidos por ser difíciles de tratar, como los tumores de vejiga, los cánceres de pulmón y ciertas formas de cáncer de mama.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fi": {
            key:"value": string:"<p>Lääkeyhtiöt AstraZeneca ja MSD tekevät merkittävää edistystä syöpien hoidossa, jotka tunnetaan vaikeasti hoidettavina, kuten rakko- ja keuhkosyövät sekä tietyt rintasyövän muodot.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"fr": {
            key:"value": string:"<p>Les entreprises pharmaceutiques AstraZeneca et MSD réalisent des progrès considérables dans le traitement des cancers qui sont connus pour être difficiles à traiter, tels que les tumeurs de la vessie, les cancers du poumon et certaines formes de cancer du sein.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hr": {
            key:"value": string:"<p>Farmaceutske tvrtke AstraZeneca i MSD postižu značajan napredak u liječenju karcinoma koji su poznati po tome što su teški za liječenje, poput tumora mjehura, karcinoma pluća i određenih oblika karcinoma dojke.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"hu": {
            key:"value": string:"<p>AstraZeneca és az MSD gyógyszeripari vállalatok jelentős előrelépést tesznek a nehezen kezelhető rákos megbetegedések, például a hólyagdaganatok, tüdőrákok és bizonyos emlőrákformák kezelésében.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"it": {
            key:"value": string:"<p>Le aziende farmaceutiche AstraZeneca e MSD stanno facendo notevoli progressi nel trattamento dei tumori che sono noti per essere difficili da trattare, come i tumori della vescica, i tumori polmonari e alcune forme di cancro al seno.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"nl": {
            key:"value": string:"<p>De farmaceutische bedrijven AstraZeneca en MSD boeken aanzienlijke vooruitgang in de behandeling van kankers die bekend staan om moeilijk te behandelen te zijn, zoals blaastumoren, longkankers en bepaalde vormen van borstkanker.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pl": {
            key:"value": string:"<p>Firmy farmaceutyczne AstraZeneca i MSD poczyniły znaczne postępy w leczeniu nowotworów, które są znane z trudności w leczeniu, takich jak guzy pęcherza, nowotwory płuc i niektóre formy raka piersi.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"pt": {
            key:"value": string:"<p>As empresas farmacêuticas AstraZeneca e MSD estão fazendo progressos consideráveis no tratamento de cânceres que são conhecidos por serem difíceis de tratar, como tumores na bexiga, cânceres de pulmão e certas formas de câncer de mama.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ro": {
            key:"value": string:"<p>Companiile farmaceutice AstraZeneca și MSD fac progrese considerabile în tratamentul cancerelor care sunt cunoscute pentru dificultatea de a fi tratate, cum ar fi tumorile vezicii urinare, cancerele pulmonare și anumite forme de cancer mamar.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"ru": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"sk": {
            key:"value": string:"<p>Farmaceutické spoločnosti AstraZeneca a MSD dosahujú značný pokrok v liečbe rakovín, ktoré sú známe svojou ťažkou liečbou, ako sú nádory močového mechúra, rakoviny pľúc a určité formy rakoviny prsníka.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"sv": {
            key:"value": null:null,
            key:"engine": null:null
        },
        key:"tr": {
            key:"value": string:"<p>İlaç şirketleri AstraZeneca ve MSD, mesane tümörleri, akciğer kanserleri ve belirli meme kanseri türleri gibi tedavi edilmesi zor olarak bilinen kanserlerin tedavisinde önemli ilerlemeler kaydediyor.</p>\n",
            key:"engine": string:"gpt-4o-mini-2024-07-18"
        },
        key:"uk": {
            key:"value": null:null,
            key:"engine": null:null
        }
    },
    key:"revisionId": string:"vayyiloxdostqrlkgfrctiz3omy",
    key:"pubDate": string:"2024-09-18T07:13:00",
    key:"contentUrl": {
        key:"en": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromContentUrl": boolean:true,
            key:"firstLanguage": boolean:true
        },
        key:"bg": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"cs": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"de": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"el": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"es": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"fi": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"fr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"hr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"hu": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"it": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"nl": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"pl": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"pt": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"ro": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"ru": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"sk": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"sr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"sv": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"tr": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        },
        key:"uk": {
            key:"value": string:"https://soundcloud.com/aracityradio/whats-right-pharma-companies-making-progress-in-cancer-treatment",
            key:"fromLang": string:"en"
        }
    },
    key:"languageDetails": {
        key:"OriginalLanguages": number:1,
        key:"ContentItemLanguages": number:1,
        key:"ContentItemTranslations": number:21
    },
    key:"originalLanguages": {
        key:"language_codes": [
            string:"en"
        ]
    },
    key:"revision": {
        key:"dateModified": string:"2025-03-17T08:39:43.26",
        key:"__typename": string:"Revision"
    },
    key:"mediaAssets": {
        key:"nodes": [
            {
                key:"uid": string:"eayrf7c7zcowqrqj63cumznp3ka",
                key:"mediaType": string:"audio/mpeg",
                key:"title": {
                    key:"en": {
                        key:"value": string:"What's right: Pharma companies making progress in cancer treatment"
                    }
                },
                key:"duration": number:0,
                key:"files": {
                    key:"nodes": [
                        {
                            key:"contentUrl": string:"https://feeds.soundcloud.com/stream/1918614656-aracityradio-whats-right-pharma-companies-making-progress-in-cancer-treatment.mp3",
                            key:"mimeType": string:"audio/mpeg",
                            key:"__typename": string:"File"
                        }
                    ],
                    key:"__typename": string:"MediaAssetFilesByFileToMediaAssetBAndAManyToManyConnection"
                },
                key:"__typename": string:"MediaAsset"
            },
            {
                key:"uid": string:"eayyilowaou4ar4v32r6epgazw4",
                key:"mediaType": string:"image/jpeg",
                key:"title": {
                    key:"en": {
                        key:"value": string:"What's right: Pharma companies making progress in cancer treatment"
                    }
                },
                key:"duration": number:0,
                key:"files": {
                    key:"nodes": [
                        {
                            key:"contentUrl": string:"https://i1.sndcdn.com/artworks-JBMZW1UoL5YpS9XV-EQQkwA-t3000x3000.jpg",
                            key:"mimeType": string:"image/jpeg",
                            key:"__typename": string:"File"
                        }
                    ],
                    key:"__typename": string:"MediaAssetFilesByFileToMediaAssetBAndAManyToManyConnection"
                },
                key:"__typename": string:"MediaAsset"
            }
        ],
        key:"__typename": string:"ContentItemMediaAssetsByContentItemToMediaAssetAAndBManyToManyConnection"
    },
    key:"contentItemTranslations": {
        key:"nodes": [
            {
                key:"title": string:"Co je správné: Farmaceutické společnosti dosahují pokroku v léčbě rakoviny",
                key:"uid": string:"01ef2934-21df-4c2a-9827-c49864e729e3",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Farmaceutické společnosti AstraZeneca a MSD dosahují značného pokroku v léčbě rakovin, které jsou známé tím, že se obtížně léčí, jako jsou nádory močového měchýře, rakoviny plic a některé formy rakoviny prsu.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:36:38.299",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Farmaceutické společnosti AstraZeneca a MSD dosahují značného pokroku v léčbě rakovin, které jsou známé svou obtížností na léčbu, jako jsou nádory močového měchýře, rakoviny plic a určité formy rakoviny prsu.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"cs",
                key:"updatedAt": string:"2025-02-10T13:36:52.209",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Фармацевтические компании добиваются успехов в лечении рака",
                key:"uid": string:"059f6520-335c-40a8-983b-b75329ce788b",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-12T11:55:30.875",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"ru",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Що правильно: Фармацевтичні компанії досягають успіхів у лікуванні раку",
                key:"uid": string:"1169fd34-dadd-4176-ae44-d9fdc70d422f",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-12T11:53:55.322",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"uk",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Lo que es correcto: Las empresas farmacéuticas están avanzando en el tratamiento del cáncer",
                key:"uid": string:"118b8a70-8903-4e41-a04e-7f89c455a326",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Las compañías farmacéuticas AstraZeneca y MSD están logrando un progreso considerable en el tratamiento de cánceres que son conocidos por ser difíciles de tratar, como los tumores de vejiga, los cánceres de pulmón y ciertas formas de cáncer de mama.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:26:58.49",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Las compañías farmacéuticas AstraZeneca y MSD están logrando un progreso considerable en el tratamiento de cánceres que son conocidos por ser difíciles de tratar, como los tumores de vejiga, los cánceres de pulmón y ciertas formas de cáncer de mama.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"es",
                key:"updatedAt": string:"2025-02-10T13:26:58.491",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"O que está certo: Empresas farmacêuticas fazendo progressos no tratamento do câncer",
                key:"uid": string:"139655ea-63cc-41ca-a24c-2d64c1729d7c",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"As empresas farmacêuticas AstraZeneca e MSD estão fazendo progressos consideráveis no tratamento de cânceres que são conhecidos por serem difíceis de tratar, como tumores na bexiga, cânceres de pulmão e certas formas de câncer de mama.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:17:33.385",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"As empresas farmacêuticas AstraZeneca e MSD estão fazendo progressos consideráveis no tratamento de cânceres que são conhecidos por serem difíceis de tratar, como tumores na bexiga, cânceres de pulmão e certas formas de câncer de mama.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"pt",
                key:"updatedAt": string:"2025-02-10T13:17:33.386",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Mi a helyes: A gyógyszeripari cégek előrelépéseket tesznek a rákkezelésben",
                key:"uid": string:"147fdf10-9bcb-4ff9-82eb-2a8807c52a9c",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"AstraZeneca és az MSD gyógyszeripari vállalatok jelentős előrelépést tesznek a nehezen kezelhető rákos megbetegedések, például a hólyagdaganatok, tüdőrákok és bizonyos emlőrákformák kezelésében.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:30:37.776",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"AstraZeneca és az MSD gyógyszergyárak jelentős előrelépéseket tesznek a nehezen kezelhető rákos megbetegedések, például a hólyagdaganatok, tüdőrákok és bizonyos formájú emlőrákok kezelésében.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"hu",
                key:"updatedAt": string:"2025-02-10T12:30:37.777",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Vad är rätt: Läkemedelsföretag gör framsteg inom cancerbehandling",
                key:"uid": string:"222f18b6-6c85-4e49-8c9a-436de59c07a0",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-12T11:54:58.179",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sv",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Правилно е: Фармацевтични компании напредват в лечението на рак",
                key:"uid": string:"2653ecdd-a41f-4ecb-b195-2ec26d88dc57",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Фармацевтичните компании AstraZeneca и MSD правят значителен напредък в лечението на ракови заболявания, които са известни с трудността си на лечение, като тумори на пикочния мехур, рак на белия дроб и определени форми на рак на гърдата.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:23:11.217",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Фармацевтичните компании AstraZeneca и MSD правят значителен напредък в лечението на ракови заболявания, които са известни с трудността си на лечение, като тумори на пикочния мехур, белодробни ракове и определени форми на рак на гърдата.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"bg",
                key:"updatedAt": string:"2025-02-10T13:23:29.451",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Što je ispravno: Farmaceutske tvrtke napreduju u liječenju raka",
                key:"uid": string:"2a6e08e5-712b-4c45-a122-1a9b59f9a2c3",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Farmaceutske tvrtke AstraZeneca i MSD postižu značajan napredak u liječenju karcinoma koji su poznati po tome što su teški za liječenje, poput tumora mjehura, karcinoma pluća i određenih oblika karcinoma dojke.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:44:30.905",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Farmaceutske tvrtke AstraZeneca i MSD postižu značajan napredak u liječenju raka koji su poznati po tome što su teški za liječenje, poput tumora mjehura, raka pluća i određenih oblika raka dojke.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"hr",
                key:"updatedAt": string:"2025-02-10T12:44:30.906",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Mikä on oikein: Lääketeollisuus tekee edistystä syövän hoidossa",
                key:"uid": string:"38b98f2a-d65e-4f24-b5b3-e6c47dd75804",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Lääkeyhtiöt AstraZeneca ja MSD tekevät merkittävää edistystä syöpien hoidossa, jotka tunnetaan vaikeasti hoidettavina, kuten rakko- ja keuhkosyövät sekä tietyt rintasyövän muodot.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:48:41.885",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Lääkeyhtiöt AstraZeneca ja MSD tekevät merkittävää edistystä syöpien hoidossa, jotka tunnetaan vaikeasti hoidettavina, kuten rakko- ja keuhkosyövät sekä tietyt rintasyövän muodot.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"fi",
                key:"updatedAt": string:"2025-02-10T12:49:00.553",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Co jest właściwe: Firmy farmaceutyczne robią postępy w leczeniu raka",
                key:"uid": string:"42fd2ba2-fb1c-4cc7-896b-be090773ff12",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Firmy farmaceutyczne AstraZeneca i MSD poczyniły znaczne postępy w leczeniu nowotworów, które są znane z trudności w leczeniu, takich jak guzy pęcherza, nowotwory płuc i niektóre formy raka piersi.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:08:50.733",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Firmy farmaceutyczne AstraZeneca i MSD poczyniły znaczne postępy w leczeniu nowotworów, które są znane z trudności w leczeniu, takich jak guzy pęcherza, nowotwory płuc i niektóre formy raka piersi.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"pl",
                key:"updatedAt": string:"2025-02-10T13:09:08.929",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"İlaç şirketleri kanser tedavisinde ilerleme kaydediyor",
                key:"uid": string:"49107c13-a371-428e-8576-29e683012d17",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"İlaç şirketleri AstraZeneca ve MSD, mesane tümörleri, akciğer kanserleri ve belirli meme kanseri türleri gibi tedavi edilmesi zor olarak bilinen kanserlerin tedavisinde önemli ilerlemeler kaydediyor.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:38:02.948",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"İlaç şirketleri AstraZeneca ve MSD, mesane tümörleri, akciğer kanserleri ve belirli meme kanseri türleri gibi tedavi edilmesi zor olarak bilinen kanserlerin tedavisinde önemli ilerlemeler kaydediyor.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"tr",
                key:"updatedAt": string:"2025-02-10T13:38:32.06",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"What's right: Pharma companies making progress in cancer treatment",
                key:"uid": string:"499dc17c-d140-42a6-b81e-de5ba1e69dc0",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-01-24T10:47:14.819",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Pharmaceutical companies AstraZeneca and MSD are making considerable progress in treating cancers that are known for being hard to treat, such as bladder tumours, lung cancers and certain forms of breast cancer.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"en",
                key:"updatedAt": string:"2025-02-10T12:59:47.503",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Cosa c'è di giusto: le aziende farmaceutiche stanno facendo progressi nel trattamento del cancro",
                key:"uid": string:"4ed72afb-5fa6-4ae9-9fcf-82b551865fb0",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Le aziende farmaceutiche AstraZeneca e MSD stanno facendo notevoli progressi nel trattamento dei tumori che sono noti per essere difficili da trattare, come i tumori della vescica, i tumori polmonari e alcune forme di cancro al seno.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:37:56.238",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Le aziende farmaceutiche AstraZeneca e MSD stanno facendo notevoli progressi nel trattamento dei tumori che sono noti per essere difficili da trattare, come i tumori della vescica, i tumori polmonari e alcune forme di cancro al seno.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"it",
                key:"updatedAt": string:"2025-02-10T12:38:10.153",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Šta je ispravno: Farmaceutske kompanije napreduju u lečenju raka",
                key:"uid": string:"9a99b868-04a4-4cb7-8982-9f17aad48f28",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": null:null,
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-17T07:25:13.705",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": null:null,
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sr",
                key:"updatedAt": null:null,
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Τι είναι σωστό: Οι φαρμακευτικές εταιρείες κάνουν πρόοδο στη θεραπεία του καρκίνου",
                key:"uid": string:"9bd9eade-350b-4bce-87ab-2e88332ca092",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Οι φαρμακευτικές εταιρείες AstraZeneca και MSD κάνουν σημαντική πρόοδο στη θεραπεία καρκίνων που είναι γνωστοί για την δυσκολία τους στη θεραπεία, όπως οι όγκοι της ουροδόχου κύστης, οι καρκίνοι του πνεύμονα και ορισμένες μορφές καρκίνου του μαστού.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:25:34.586",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Οι φαρμακευτικές εταιρείες AstraZeneca και MSD κάνουν σημαντική πρόοδο στη θεραπεία καρκίνων που είναι γνωστοί για την δυσκολία τους στη θεραπεία, όπως οι όγκοι της ουροδόχου κύστης, οι καρκίνοι του πνεύμονα και ορισμένες μορφές καρκίνου του μαστού.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"el",
                key:"updatedAt": string:"2025-02-10T13:26:01.218",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Qu'est-ce qui est juste : Les entreprises pharmaceutiques progressent dans le traitement du cancer",
                key:"uid": string:"a2935243-3d58-4155-b9cf-b1cc32abb53d",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Les entreprises pharmaceutiques AstraZeneca et MSD réalisent des progrès considérables dans le traitement des cancers qui sont connus pour être difficiles à traiter, tels que les tumeurs de la vessie, les cancers du poumon et certaines formes de cancer du sein.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:35:26.394",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Les entreprises pharmaceutiques AstraZeneca et MSD réalisent des progrès considérables dans le traitement des cancers qui sont connus pour être difficiles à traiter, tels que les tumeurs de la vessie, les cancers du poumon et certaines formes de cancer du sein.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"fr",
                key:"updatedAt": string:"2025-02-10T12:35:41.263",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Wat is juist: Farmaceutische bedrijven maken vooruitgang in de behandeling van kanker",
                key:"uid": string:"b9660bfe-4082-4771-a8bf-df23a0e695c9",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"De farmaceutische bedrijven AstraZeneca en MSD boeken aanzienlijke vooruitgang in de behandeling van kankers die bekend staan om moeilijk te behandelen te zijn, zoals blaastumoren, longkankers en bepaalde vormen van borstkanker.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T13:32:59.084",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"De farmaceutische bedrijven AstraZeneca en MSD boeken aanzienlijke vooruitgang in de behandeling van kankers die bekend staan om moeilijk te behandelen te zijn, zoals blaastumoren, longkankers en bepaalde vormen van borstkanker.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"nl",
                key:"updatedAt": string:"2025-02-10T13:33:13.776",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Ce este corect: Companiile farmaceutice fac progrese în tratamentul cancerului",
                key:"uid": string:"b98e7eaa-c1f5-470a-aab5-bc339da6968a",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Companiile farmaceutice AstraZeneca și MSD fac progrese considerabile în tratamentul cancerelor care sunt cunoscute pentru dificultatea de a fi tratate, cum ar fi tumorile vezicii urinare, cancerele pulmonare și anumite forme de cancer mamar.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:55:29.517",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Companiile farmaceutice AstraZeneca și MSD fac progrese considerabile în tratamentul cancerelor care sunt cunoscute pentru dificultatea lor de tratament, cum ar fi tumorile vezicii urinare, cancerele pulmonare și anumite forme de cancer mamar.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"ro",
                key:"updatedAt": string:"2025-02-10T12:55:46.164",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Was richtig ist: Pharmaunternehmen machen Fortschritte bei der Krebsbehandlung",
                key:"uid": string:"c551144f-d4f2-4bc5-a919-3221d39f3485",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Die Pharmaunternehmen AstraZeneca und MSD machen erhebliche Fortschritte bei der Behandlung von Krebsarten, die als schwer behandelbar bekannt sind, wie Blasentumoren, Lungenkrebs und bestimmte Formen von Brustkrebs.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:31:49.083",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Die Pharmaunternehmen AstraZeneca und MSD machen erhebliche Fortschritte bei der Behandlung von Krebsarten, die als schwer behandelbar bekannt sind, wie z. B. Blasentumoren, Lungenkrebs und bestimmte Formen von Brustkrebs.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"de",
                key:"updatedAt": string:"2025-02-10T12:31:49.084",
                key:"__typename": string:"ContentItemTranslation"
            },
            {
                key:"title": string:"Čo je správne: Farmaceutické spoločnosti dosahujú pokrok v liečbe rakoviny",
                key:"uid": string:"d543e38d-cd27-42de-8983-741b80ca82b7",
                key:"autoTeaserLong": null:null,
                key:"autoTeaserShort": null:null,
                key:"content": string:"Farmaceutické spoločnosti AstraZeneca a MSD dosahujú značný pokrok v liečbe rakovín, ktoré sú známe svojou ťažkou liečbou, ako sú nádory močového mechúra, rakoviny pľúc a určité formy rakoviny prsníka.",
                key:"contentCleaned": null:null,
                key:"contentItemUid": string:"eayrf7c7zcoxaro2tisteiwv24i",
                key:"createdAt": string:"2025-02-10T12:40:13.554",
                key:"engine": string:"gpt-4o-mini-2024-07-18",
                key:"metadata": null:null,
                key:"revisionId": string:"vayrf7daohhbar42d6tkci5pvyk",
                key:"subtitle": null:null,
                key:"summary": string:"Farmaceutické spoločnosti AstraZeneca a MSD dosahujú značný pokrok v liečbe rakovín, ktoré sú známe svojou ťažkou liečbou, ako sú nádory močového mechúra, rakoviny pľúc a určité formy rakoviny prsníka.",
                key:"summaryCleaned": null:null,
                key:"targetLanguage": string:"sk",
                key:"updatedAt": string:"2025-02-10T12:40:56.238",
                key:"__typename": string:"ContentItemTranslation"
            }
        ],
        key:"totalCount": number:21,
        key:"__typename": string:"ContentItemTranslationsConnection"
    },
    key:"__typename": string:"ContentItem"
}